Jonathan R. Goodman - Net Worth and Insider Trading
Jonathan R. Goodman Net Worth
The estimated net worth of Jonathan R. Goodman is at least $523,400 dollars as of 2024-05-14. Jonathan R. Goodman is the Director of POINT Biopharma Global Inc and owns about 41,872 shares of POINT Biopharma Global Inc (PNT) stock worth over $523,400. Details can be seen in Jonathan R. Goodman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan R. Goodman has not made any transactions after 2022-11-18 and currently still holds the listed stock(s).
Transaction Summary of Jonathan R. Goodman
Jonathan R. Goodman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan R. Goodman owns 1 companies in total, including POINT Biopharma Global Inc (PNT) .
Click here to see the complete history of Jonathan R. Goodman’s form 4 insider trades.
Insider Ownership Summary of Jonathan R. Goodman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PNT | POINT Biopharma Global Inc | 2022-11-18 | director |
Jonathan R. Goodman Latest Holdings Summary
Jonathan R. Goodman currently owns a total of 1 stock. Jonathan R. Goodman owns 41,872 shares of POINT Biopharma Global Inc (PNT) as of November 18, 2022, with a value of $523,400.
Latest Holdings of Jonathan R. Goodman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PNT | POINT Biopharma Global Inc | 2022-11-18 | 41,872 | 12.50 | 523,400 |
Holding Weightings of Jonathan R. Goodman
Jonathan R. Goodman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan R. Goodman has made a total of 1 transactions in POINT Biopharma Global Inc (PNT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in POINT Biopharma Global Inc is the acquisition of 6,000 shares on November 18, 2022, which cost Jonathan R. Goodman around $37,980.
Insider Trading History of Jonathan R. Goodman
- 1
Jonathan R. Goodman Trading Performance
GuruFocus tracks the stock performance after each of Jonathan R. Goodman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan R. Goodman is 16.8%. GuruFocus also compares Jonathan R. Goodman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan R. Goodman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan R. Goodman's insider trading performs compared to the benchmark.
Performance of Jonathan R. Goodman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.85 | | | | | |
| Relative Return to S&P 500(%) | 4.7 | | | | | |
Jonathan R. Goodman Ownership Network
Jonathan R. Goodman Owned Company Details
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Jonathan R. Goodman is the director of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Jonathan R. Goodman made 1 insider transaction in POINT Biopharma Global Inc (PNT) with a net purchase of 6,000. Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P , a net purchase of 50,000 shares made by Allan C Silber , and a net purchase of 3,700 shares made by Rajesh Malik .
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 70,830 shares were bought by its insiders, resulting in a net sale of 17,090,448 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
Jonathan R. Goodman Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan R. Goodman. You might contact Jonathan R. Goodman via mailing address: 4850 West 78th Street, Indianapolis In 46268.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
